We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Labeled Complementary Nucleic Acid Strand Localizes Tissue Section Sequences

By LabMedica International staff writers
Posted on 28 Jan 2010
Rapid in situ hybridization (ISH) was successfully demonstrated on a new wave reactant-product decoupling (RPD) system. More...


ISH uses a labeled complementary DNA or RNA strand to localize a specific sequence in a section of tissue. This is distinct from immunohistochemistry, which localizes proteins in tissue sections.

The wave system is a rapid IHC System designed to enhance capabilities of the anatomic pathology laboratory, provide clinicians with rapid, reliable, actionable diagnostic information, and advance patient care.

In 2008, Celerus Diagnostics (Carpinteria, CA, USA) introduced rapid IHC with its wave system, a semiautomated platform that delivers high-quality IHC results in 15 minutes. The addition of on-board pretreatment steps to the existing 15-minute staining protocols, results in totally automated IHC in one hour, compared to industry standards of two-and-a-half-four hours.

Celerus Diagnostics will launch the wave RPD system, a totally automated immunohistochemistry (IHC) and in situ-hybridization (ISH) staining system to the market this year. It will be introduced at the United States and Canadian Association of Pathologists (USCAP) annual meeting to be held in Washington DC, (USA) on March 22-24, 2010.

"We've had success with both fluorescent and chromogenic markers," said Jason Lusk, vice president of business development at Celerus. "This is significant because the importance of molecular targets as companion diagnostics to identify patients for drug therapies continues to grow."

Related Links:
Celerus Diagnostics


New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Automated Urinalysis Solution
UN-9000
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.